![Rebecca Evans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rebecca Evans
Direttore operativo presso XingImaging LLC (Connecticut)
Profilo
Rebecca Evans currently works at XingImaging LLC (Connecticut), as Chief Operating Officer from 2019.
Posizioni attive di Rebecca Evans
Società | Posizione | Inizio |
---|---|---|
XingImaging LLC (Connecticut)
![]() XingImaging LLC (Connecticut) Miscellaneous Commercial ServicesCommercial Services XingImaging LLC is a full-service CRO company based in Madison, CT. XingImaging provides the capability for PET radiotracer production and PET acquisition, supporting multi-center trials in the US and China, which require PET for study eligibility, disease evaluation, and treatment efficacy. The PET production facilities in the XingImaging network are located at class-4 hospitals in China, and the company is currently expanding to other regions. XingImaging is committed to producing radiotracers to support clinical trials in Alzheimer's disease. The company was founded in 2018 by Gilles Tamagnan, Piu Chan, John Seibyl, and Kenneth Marek, with Gilles Tamagnan serving as the CEO since then. The company has established a network of radiopharmaceutical tracer production and imaging centers for PET acquisition and image analysis, utilizing the most advanced neuroimaging tracer compounds available to be used in AD clinical trials. | Direttore operativo | 01/06/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
XingImaging LLC (Connecticut)
![]() XingImaging LLC (Connecticut) Miscellaneous Commercial ServicesCommercial Services XingImaging LLC is a full-service CRO company based in Madison, CT. XingImaging provides the capability for PET radiotracer production and PET acquisition, supporting multi-center trials in the US and China, which require PET for study eligibility, disease evaluation, and treatment efficacy. The PET production facilities in the XingImaging network are located at class-4 hospitals in China, and the company is currently expanding to other regions. XingImaging is committed to producing radiotracers to support clinical trials in Alzheimer's disease. The company was founded in 2018 by Gilles Tamagnan, Piu Chan, John Seibyl, and Kenneth Marek, with Gilles Tamagnan serving as the CEO since then. The company has established a network of radiopharmaceutical tracer production and imaging centers for PET acquisition and image analysis, utilizing the most advanced neuroimaging tracer compounds available to be used in AD clinical trials. | Commercial Services |
- Borsa valori
- Insiders
- Rebecca Evans